Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hepatitis B immune globulin - Biotest

Next Previous
Search
Drug Profile

Hepatitis B immune globulin - Biotest

Alternative Names: BT-088; Fovepta; HBVIg - Biotest AG; Hepatect; Hepatect CP; Hepatect FH; Human hepatitis B immunoglobulin - Biotest AG; Neohepatect; Zutectra

Latest Information Update: 27 Apr 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biotest AG
  • Class Antivirals; Immunoglobulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatitis B

Most Recent Events

  • 25 Apr 2022 Biotest AG has been acquired by Grifols
  • 05 Sep 2019 Discontinued - Phase-III for Hepatitis B (In the elderly, Prevention of relapse, In adults) in Germany, Italy (IV)
  • 23 Apr 2015 Biotest files an MAA application with the EMA in European Union early use hepatitis B immunoglobulin in Hepatitis B (prevention of relapse in liver transplant patients)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top